Endocyte, Inc. Announces Presentations at the 244th American Chemical Society Meeting & Exposition

Published: Aug 14, 2012

WEST LAFAYETTE, Ind., Aug. 14, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that three posters will be presented by Endocyte scientists at the 244th American Chemical Society (ACS) Meeting & Exposition to be held in Philadelphia, Aug. 19 – 23, 2012.

Back to news